Profil
Cora Holland Haffner is currently the Director of Operations at Chartline Capital Management LLC.
She has a graduate degree from Chestnut Hill College, which she received in 2000, and an undergraduate degree from West Virginia Wesleyan College, which she received in 1994.
Aktiva positioner av Cora Haffner
| Företag | Position | Start |
|---|---|---|
Chartline Capital Management LLC
Chartline Capital Management LLC Investment ManagersFinance Chartline Capital seeks investment opportunities in companies located in the United States with an annual revenue of USD 2 - 7 million. The firm focuses on companies operating in HR tech, fintech, digital industrials and proptech and real estate sectors. It does not invest in seed or pre-seed, pre-IPO secondaries, beltway growth rounds and sectors such as B2C, crypto, material science therapeutics. It provides financing for early-stage capital requirements with transaction sizes of USD 0.50 - USD 5 million. | Privat kapitalinvesterare | - |
Cora Haffners utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Chestnut Hill College
Chestnut Hill College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Virginia Wesleyan College
West Virginia Wesleyan College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chartline Capital Management LLC
Chartline Capital Management LLC Investment ManagersFinance Chartline Capital seeks investment opportunities in companies located in the United States with an annual revenue of USD 2 - 7 million. The firm focuses on companies operating in HR tech, fintech, digital industrials and proptech and real estate sectors. It does not invest in seed or pre-seed, pre-IPO secondaries, beltway growth rounds and sectors such as B2C, crypto, material science therapeutics. It provides financing for early-stage capital requirements with transaction sizes of USD 0.50 - USD 5 million. | Finance |
















